1. Home
  2. OMER vs HBT Comparison

OMER vs HBT Comparison

Compare OMER & HBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Omeros Corporation

OMER

Omeros Corporation

N/A

Current Price

$13.29

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Logo HBT Financial Inc.

HBT

HBT Financial Inc.

N/A

Current Price

$35.37

Market Cap

1.3B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
OMER
HBT
Founded
1994
1920
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2008
2019

Fundamental Metrics

Financial Performance
Metric
OMER
HBT
Price
$13.29
$35.37
Analyst Decision
Buy
Buy
Analyst Count
3
5
Target Price
$27.50
★ $42.00
AVG Volume (30 Days)
★ 1.2M
95.1K
Earning Date
11-16-2026
10-26-2026
Dividend Yield
N/A
★ 2.81%
EPS Growth
★ 98.15
7.96
EPS
0.13
★ 1.99
Revenue
★ $29,868,000.00
N/A
Revenue This Year
N/A
$33.02
Revenue Next Year
$66.13
$24.31
P/E Ratio
$107.77
★ $17.89
Revenue Growth
N/A
★ N/A
52 Week Low
$6.70
$23.62
52 Week High
$21.24
$38.79

Technical Indicators

Market Signals
Indicator
OMER
HBT
Relative Strength Index (RSI) 30.78 38.82
Support Level $9.45 $34.95
Resistance Level $19.68 $37.11
Average True Range (ATR) 0.92 0.89
MACD -0.45 -0.25
Stochastic Oscillator 8.90 6.56

Price Performance

Historical Comparison
OMER
HBT

About OMER Omeros Corporation

Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program.

About HBT HBT Financial Inc.

HBT Financial Inc provides a comprehensive suite of business, commercial, wealth management, and retail banking products and services to individuals, businesses, and municipal entities throughout Central and Northeastern Illinois and Eastern Iowa. It operates through one reportable segment: community banking. It generates revenue from Card income, Wealth management fees, and Service charges on deposit accounts.

Share on Social Networks: